Fiona Levy MD Appointed Medical Director of Cohen Children’s Medical Center

Fiona Levy MD will oversee the hospital’s medical staff, lead staff engagement and development while participating in community outreach efforts for the largest provider of pediatric health services in New York State.

Cohen Children’s has been rated the No. 1 children’s hospital in the state and earned top national rankings for exceptional care in nine pediatric specialties, according to US News & World Report’s 2021-2022 Best Children’s Hospitals. Dr. Levy, who will also serve as vice president for Northwell’s pediatric service line, succeeds Peter Silver, MD, who was recently named senior vice president and chief quality officer at the health system.

“Having Dr. Levy back here at Cohen Children’s will be such a great asset for us,” said Charles Schleien, MD, senior vice president and chair of pediatric services at Northwell. “Her experience in clinical and administrative duties, as well as her intellect, personality and ability to get through difficult issues will be recognized by everyone in our hospital as a major positive.”

Fiona Levy MD rejoins Cohen Children’s after a stint at NYU Langone Health’s Hassenfeld Children’s Hospital, where she served as executive director of the Sala Institute for Child and Family Centered Care since 2014. She also was vice chair of clinical affairs for the Department of Pediatrics at the NYU School of Medicine.

From 2011-2014, Dr. Levy served as an attending physician in the intensive care unit at Cohen Children’s as well as the hospital’s vice president and chief quality officer. Dr. Levy began her medical career at children’s hospitals in St. Louis, MO, and Dallas, TX.

Fiona Levy MD earned her medical degree from New York Medical College in Valhalla, a master of business administration from Washington University in St. Louis, MO, and a bachelor of science in chemistry from Wellesley College, MA. She completed her residency at SUNY Health Scirnce Center in Syracuse and a fellowship at Children’s Hospital and Medical Center in Seattle, WA.

“We are thrilled to welcome back Dr. Levy. She brings with her many years of patient-focused care with an emphasis on exemplary quality outcomes,” said Carolyn Quinn, RN, senior vice president of pediatrics at Northwell and executive director of Cohen Childen’s Medical Center. “Dr Levy is a welcomed addition to our executive leadership team.”

In addition, Nancy Palumbo, MD, who served as the hospital’s interim medical director since January, has been promoted to associate medical director for Cohen Children’s. Prior to that, Dr. Palumbo was chief of hospital medicine. She joined Cohen Children’s in 2008.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”